Study of Retinal Oxygenation in Central Retinal Vein Occlusion

NCT ID: NCT02523339

Last Updated: 2021-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

117 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2020-11-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to test if oxygen saturation in retinal vessels is correlated with clinical parameters, such as visual acuity, central retinal thickness and presence of neovascularization. Retinal oximetry is performed with fundus camera based oximeters. The study will not entail change in treatment of the disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Vein Occlusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Suspected central retinal vein occlusion.
* Informed consent for participation.
* No treatment before the first oximetry measurement.

Exclusion Criteria

* History of cardiovascular or respiratory diseases that can be expected to influence systemic or retinal oxygen saturation. Examples: Known COPD or carotid stenosis. Subjects with high blood pressure will not be excluded but blood pressure should be registered.
* Poor quality images will be excluded based on the images themselves. Therefore, grading of cataract or other media opacities is not strictly necessary for the purpose of the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Basel, Switzerland

OTHER

Sponsor Role collaborator

Aston University

OTHER

Sponsor Role collaborator

University of Jena

OTHER

Sponsor Role collaborator

Medical University of Vienna

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role collaborator

Clinical Research Center Memorial A. de Rothschild

UNKNOWN

Sponsor Role collaborator

Palacky University

OTHER

Sponsor Role collaborator

University of Toyama

OTHER

Sponsor Role collaborator

University of Iceland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sveinn Hakon Hardarson

Post-doctoral researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sveinn H. Hardarson, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Iceland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Clinical Pharmacology, Medical University of Vienna

Vienna, , Austria

Site Status

Department of Ophthalmology, University Hospital and Faculty of Medicine and Dentistry, Palacky University Olomouc

Olomouc, , Czechia

Site Status

Aarhus University. Department of Clinical Medicine - The Department of Ophthalmology

Aarhus, , Denmark

Site Status

University Hospital Jena

Jena, , Germany

Site Status

University of Iceland / Landspitali, Dept. of Ophthalmology

Reykjavik, , Iceland

Site Status

Eye Clinic of the University Hospital Basel

Basel, Canton of Basel-City, Switzerland

Site Status

Clinical Research Center Memorial A. de Rothschild

Geneva, , Switzerland

Site Status

Aston University School of Life and Health Sciences

Birmingham, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Czechia Denmark Germany Iceland Switzerland United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UI-CRVO-2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OCT in Retinal Vein Occlusions
NCT01992575 COMPLETED